BioCorRx (BICX) Interest Expenses (2011 - 2026)

BioCorRx has disclosed Interest Expenses across 16 years of filings, most recently posting $31041.0 for Q1 2026.

• Interest Expenses for Q1 2026 came in at $31041.0, down 64.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $290426.0 (down 57.44% YoY), and the FY2025 annual result was $223850.0, down 71.18% from the prior year.
• Interest Expenses came in at $31041.0 for Q1 2026 at BioCorRx, down from $193027.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $317907.0 in Q2 2024 to a low of $13276.0 in Q1 2022.
• The 5-year median for Interest Expenses is $36686.0 (2025), against an average of $84156.4.
• Across the five-year window, Interest Expenses slumped 95.61% in 2022 and soared 1056.49% in 2024, its largest moves.
• BioCorRx's Interest Expenses stood at $23743.0 in 2022, then surged by 45.68% to $34588.0 in 2023, then soared by 270.23% to $128054.0 in 2024, then soared by 50.74% to $193027.0 in 2025, then tumbled by 83.92% to $31041.0 in 2026.
• The last three Interest Expenses figures came in at $31041.0 (Q1 2026), $193027.0 (Q4 2025), and $29672.0 (Q3 2025), per Business Quant data.